Bluejay Diagnostics Income Statement (2020-2026) | BJDX

Income Statement Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Shares Outstanding (Entity) (Quarter)
131.00329.00266.00630.00630.00630.00632.00639.00640.00774.00774.000.00M0.00M
Revenue & cost
Revenue (Quarter)
0.25M
Gross Profit (Quarter)
0.05M
Operating items
Research & Development (Quarter)
0.23M0.44M-0.40M0.05M0.76M1.38M1.32M1.35M1.68M1.40M1.29M1.33M1.03M0.55M0.55M0.78M0.89M0.79M0.59M0.81M
Selling, General & Administrative (Quarter)
0.39M0.45M0.82M1.32M1.20M0.15M0.96M0.15M1.07M0.96M1.10M1.09M0.86M0.81M0.93M1.10M1.10M0.83M0.88M1.13M
Other Operating Expenses (Quarter)
0.05M0.07M0.96M0.69M0.08M-0.21M0.17M1.18M0.15M-0.02M687.000.01M305.00753.00816.00
Operating Expenses (Quarter)
0.67M0.96M1.37M2.07M2.03M2.81M2.45M2.68M2.90M2.34M2.39M2.43M1.90M1.36M1.48M1.89M1.99M1.62M1.46M1.94M
Operating Income (Quarter)
-0.67M-0.96M-1.37M-2.07M-1.99M-2.81M-2.45M-2.68M-2.90M-2.34M-2.39M-2.43M-1.90M-1.36M-1.48M-1.89M-1.99M-1.62M-1.46M-1.94M
EBIT (Quarter)
-0.67M-0.96M-1.37M-2.07M-1.99M-2.81M-2.45M-2.68M-2.90M-2.34M-2.39M-2.43M-1.90M-1.36M-1.48M-1.89M-1.99M-1.62M-1.46M-1.94M
Non-operating items
Interest & Investment Income (Quarter)
0.03M0.02M0.06M0.04M0.02M0.03M0.02M0.03M0.02M
Other Non Operating Income (Quarter)
-0.00M0.06M0.00M0.14M0.09M0.04M-0.08M0.07M0.03M0.01M0.01M0.01M-275.00554.00579.00731.00
Non Operating Income (Quarter)
0.03M-0.24M-0.09M0.05M0.05M-0.15M0.07M0.14M0.09M0.04M0.08M0.10M-0.58M-0.12M0.05M0.02M0.03M0.02M0.03M0.02M
Net income details
EBT (Quarter)
-0.69M-1.69M-1.48M-2.10M-2.13M-2.91M-2.49M-2.72M-3.00M-2.35M-2.43M-2.44M-2.51M-1.49M-2.12M-1.91M-1.97M-1.60M-1.43M-2.02M
Profit After Tax (Quarter)
0.64M-1.19M-1.46M-2.01M-1.94M-2.96M-2.39M-2.54M-2.81M-2.30M-2.30M-2.33M-2.48M-1.48M-1.43M-1.86M-1.96M-1.60M-1.43M-1.92M
Income from Continuing Operations (Quarter)
-0.69M-1.69M-1.48M-2.10M-2.13M-2.91M-2.49M-2.72M-3.00M-2.35M-2.43M-2.44M-2.51M-1.49M-2.12M-1.91M-1.97M-1.60M-1.43M-2.02M
Consolidated Net Income (Quarter)
-0.69M-1.69M-1.48M-2.10M-2.13M-2.91M-2.49M-2.72M-3.00M-2.35M-2.43M-2.44M-2.51M-1.49M-2.12M-1.91M-1.97M-1.60M-1.43M-2.02M
Income towards Parent Company (Quarter)
-0.69M-1.69M-1.48M-2.10M-2.13M-2.91M-2.49M-2.72M-3.00M-2.35M-2.43M-2.44M-2.51M-1.49M-2.12M-1.91M-1.97M-1.60M-1.43M-2.02M
Net Income towards Common Stockholders (Quarter)
-0.69M-1.69M-1.48M-2.10M-2.13M-2.91M-2.49M-2.72M-3.00M-2.35M-2.43M-2.44M-2.51M-14.71M-1.43M-1.91M-1.97M-1.60M-1.43M-2.02M
Additional items
EPS (Basic) (Quarter)
-0.01M-0.01M-0.01M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-307.77-31.23-13.79-5.67-4.06-3.18-2.05
EPS (Diluted) (Quarter)
-0.01M-0.01M-0.01M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-307.77-31.23-13.79-5.67-4.06-3.18-2.05
Shares Outstanding (Quarter)
131.00328.00266.00629.00630.00630.00630.00637.00639.00689.00685.000.00M0.00M0.05M0.05M0.14M0.35M0.39M0.45M0.98M
Shares Outstanding (Diluted) (Quarter)
131.00328.00266.00629.00630.00630.00630.00637.00639.00689.00685.000.00M0.00M0.05M0.05M0.14M0.35M0.39M0.45M0.98M
EBITDA (Quarter)
-0.67M-0.96M-1.37M-2.07M-1.99M-2.81M-2.45M-2.68M-2.90M-2.34M-2.39M-2.43M-1.90M-1.36M-1.48M-1.89M-1.99M-1.62M-1.46M-1.94M
Interest Expenses (Quarter)
0.02M0.73M0.11M0.03M0.14M0.10M0.04M0.04M0.10M0.01M0.04M0.04M0.63M0.19M0.67M0.04M0.01M0.01M187.000.10M